Skip to content
Trial Eligibility
Menu

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

NCT00005095

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

RATIONALE: To improve strategies for detection and prevention of early-stage disease. PURPOSE: This research study is collecting specimens and data to develop better methods for early detection and prevention of ovarian cancer among the high risk population and those who have the disease.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Cervical Cancer
  • Endometrial Cancer
  • Fallopian Tube Cancer
  • Hereditary Breast/Ovarian Cancer (brca1, brca2)
  • Ovarian Cancer
  • Sarcoma
  • Uterine Leiomyomata
  • Vaginal Cancer
  • Vulvar Cancer

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 80 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Northwestern University
Last updated on ClinicalTrials.gov
February 28, 2025

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.